HBAN vs MGX · P/E 13, rev $1.56B vs rev $25.2M
Huntington Bancshares Incorporated (HBAN) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. MGX currently screens at market cap $44.4M.
Not investment advice. Open the HBAN and MGX stock pages for the full models.
Not investment advice.